Search for: "WELLS v. EDWARDS" Results 581 - 600 of 2,378
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
8 Feb 2019, 6:04 am
Potential Changes to Fund of Funds Arrangements Posted by Thomas Hiller, Brian McCabe, and Edward Baer, Ropes & Gray LLP, on Friday, February 1, 2019 Tags: Exchange-traded funds, Investment advisers, Investment Advisers Act, Investor protection, Risk management, SEC, SEC rulemaking, Section 12(d), Securities regulation The Latest on Proxy Access Posted by Holly J. [read post]
1 Feb 2019, 12:44 pm
France Elsa Supiot & Michael Wells-Greco, Blind spots (persons and family): Blood Hans Van Loon & David Sindres, Cultural identities: Wagner v. [read post]
1 Feb 2019, 10:51 am
The field of corporate and securities law has grown with the expansion of economic activity beyond the state, as well as with the explosion of self regulatory mechanisms at the local and international level, all of which have transformed notions of legal risk (which consequentially becomes more interesting for the legal academic). [read post]
App. 2018), the court rejected a “reasonableness” approach to employee non-solicitation provisions, emphasizing the plain language of section 16600 and the California Supreme Court’s decision in Edwards v. [read post]
27 Jan 2019, 4:19 pm by INFORRM
  The claimants contend that phone hacking was widespread at the Sun as well as the News of the World. [read post]
7 Jan 2019, 9:19 am
The event involved two days of discussions focused on EU copyright reform as well as the interplay between copyright and fundamental rights. [read post]
25 Dec 2018, 9:30 pm by Series of Essays
Current Economic Regulatory Framework Works for Freight Rail Customers February 12, 2018 | Edward R. [read post]
20 Dec 2018, 4:28 pm by Giles Peaker
(For more on this, see the Supreme Court in  Edwards v Kumarasamy [2016] UKSC 40 – our note ). [read post]
20 Dec 2018, 9:22 am by Schachtman
  Selikoff received the Albert Lasker Clinical Medical Research Award for his work on the clinical trial of isoniazid to treat tuberculosis, along with Walsh McDermott and Carl Muschenheim, of the Hoffmann-La Roche Research Laboratories, and Edward H. [read post]